Filters

Pp-223 manufacturers

Filters

None products found

pp-223

Concentrate for solution for infusion

Dossier type
EU CTD
Dossier status
Under development
Country of origin
European Union
GMP approvals
EU GMP
Comments
Indication: Platinum-resistant ovarian cancer (PROC); recurrent/advanced endometrial cancer (EC) Clinical stage: Phase 3. Modality: Biological (FRα-targeted antibody-drug conjugate (ADC) — NBE) Mechanism / Target: Humanised anti-folate receptor alpha (FRα) IgG1 antibody ( conjugated to a topoisomerase I inhibitor payload (camptothecin-based); FRα highly expressed in ovarian and endometrial cancers; ADC delivers cytotoxic payload selectively to FRα-positive tumour cells via receptor-mediated internalisation; bystander killing effect on FRα-negative adjacent cells Route / form: IV infusion (Q3W)
Manufacturer #6964
Europe-based biotechnology company specializing in Rx antibody therapeutics, including approved monoclonal and bispecific antibodies. Portfolio addresses hematological cancers and other indications. Pursues global commercialization through partnerships with major pharmaceutical companies; products are approved across major regulated markets.

Want to see all products?

Subscribe today to benefit from:

  • Streamlined product sourcing - the leading CTD dossiers database focused on finished dosage formulations

  • Direct negotiations - connect and negotiate directly with manufacturers without any brokerage fee

  • Increased profitability - secure the best commercial terms for your business by comparing offers from several manufacturers

Request Subscription

Willing to unlock more features?

Please fill out form and send us your specific requirements, and we will get back to you as soon as possible

Want unlimited access to the Pipelinepharma database?

Become a subscriber to unlock:

  • Streamlined product sourcing: access the only CTD dossier pipeline and sourcing platform.

  • Direct connections: communicate directly with CTD dossier owners and manufacturers with no brokerage fees.

  • Higher profitability: compare multiple supplier offers and secure the best commercial terms.

  • Expanded network: view supplier portfolios and stay updated on new products.

  • Value-added product ideas: discover products with lower competition potential.

  • Access to marketing authorizations for sale: find already registered products in your target markets.